跳至主要内容
临床试验/NCT01937494
NCT01937494已完成不适用

Are Technicians Showing Bronchial Hyperreactivity Able to Safely Perform Bronchial Provocation Tests?

Centre Hospitalier Universitaire Saint Pierre1 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2013年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
13
试验地点
1
主要终点
spirometric values in patients exposed passively to histamine during BHR challenge

研究概览

简要总结

Bronchial hyperresponsiveness consists in excessive response to bronchial stimuli.Bronchial challenge test is used to confirm/exclude asthma (metacholine or histamine).Protection are used to avoid passive exposure of the technicians performing the test, despite the absence of evidence that they could develop a bronchoconstriction even if they suffer from BHR.The purpose of the study is to determine if patients with a high level of bronchial hyperreactivity and exposed passively to histamine during a bronchial challenge, are developing a bronchoconstriction, when placed in the same conditions that the technicians performing these tests.

详细描述

Bronchial hyperresponsiveness (BHR) consists in excessive response to bronchial stimuli.Bronchial challenge test is used to confirm/exclude asthma.BHR is also present in other diseases such as allergic rhinitis, Chronic Obstructive pulmonary disease,heart failure..

Thes test is performed with metacholine or histamine with spirometric documented response to incremental doses.Protection are used to avoid passive exposure of the technicians performing the test, despite the absence of evidence that they could develop a bronchoconstriction if they suffer from BHR.

The purpose of the study is to determine if patients, newly diagnosed with a high level of bronchial hyperreactivity and exposed passively to histamine during a bronchial challenge, are reacting to histamine when placed in the same conditions that the technicians performing these tests.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • adult patients with positive histamine challenge test (first dose)

排除标准

  • other active respiratory disease

研究组 & 干预措施

asthma patients

Experimental

patients who show a positive response at the first dos of histamine challenge test will be enrolled

干预措施: histamine-benzylic alcohol (magistral preparation) (Drug)

结局指标

主要结局

spirometric values in patients exposed passively to histamine during BHR challenge

时间窗: 1 hour

次要结局

未报告次要终点

研究者

发起方
Centre Hospitalier Universitaire Saint Pierre
申办方类型
Other
责任方
Principal Investigator
主要研究者

Marie Bruyneel

CCA, pneumologie

Centre Hospitalier Universitaire Saint Pierre

研究点 (1)

Loading locations...

相似试验